Capital Stock Repurchase Plan Transactions

3 Months Ended

Mar. 31, 2024

Capital Stock Repurchase Plan Transactions [Abstract]

Capital Stock Repurchase Plan Transactions

16.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

	Three months ended March 31,
	2024		2023
Total cost of repurchased shares (in thousands)	$	32,344	$	-
Shares repurchased		50,000		-
Weighted average price per share	$	646.87	$	-

In November 2023, the Board of Directors authorized $300.0 million for additional stock repurchase under the February 2011 repurchase program. In May and November 2021, the Board of Directors authorized a total of $600.0 million for additional stock repurchase under Chemed’s existing share repurchase program. We currently have $281.7 million of authorization remaining under this share repurchase plan.